IHS Chemical Week

Markets :: Fine Chemicals/Biotech :: Pharmaceutical ingredients

Glenmark Buys Czech Pharma Firm

1:44 PM MDT | April 4, 2007 | DR

Glenmark Pharmaceuticals Ltd.’s (Mumbai) subsidiary Glenmark Holdings (GHSA; La Chaux-de-Fonds, Switzerland) says it has acquired more than a 90% stake in Czech pharmaceutical company Medicamenta (Praha). Terms were not disclosed. Medicamenta’s 2007 projected revenue is $8 million, Glenmark says. Medicamenta has sales and marketing operations in the Czech Republic and Slovakia, and the deal gives Glenmark an entry point into those fast-growing regions, Glenmark says. The transaction is part of Glenmark’s long-term strategy to “emerge as a...

This information is only available to Chemical Week subscribers.


Forgot your user ID or password?
Click here to have it sent to you.

Not an IHS Chemical Week subscriber yet?

Here's why you should be:

  • 31 issues of Chemical Week magazine a year in print or digital format
  • Real time news and analysis on chemweek.com 
  • 20+ years of online archives
  • Topical e-newsletters that capture the most impactful events
  • Special issues with a regional or company focus
  • Global Outlook issue

Subscribe now


contact us | about us | privacy policy | sitemap

ihsCopyright © IHS, Inc.All rights reserved.Reproduction in whole or in part without permission is prohibited.

North Asia Russia Southeast Asia China India/Pakistan Middle East Eastern Europe Western Europe Central America Canada USA Australia/New Zealand South America Africa